Genetic Manipulations of PPARs: Effects on Obesity and Metabolic Disease

被引:28
作者
Barak, Yaacov [1 ]
Kim, Suyeon [1 ]
机构
[1] Jackson Lab, Bar Harbor, ME 04609 USA
关键词
D O I
10.1155/2007/12781
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The interest in genetic manipulations of PPARs is as old as their discovery as receptors of ligands with beneficial clinical activities. Considering the effects of PPAR ligands on critical aspects of systemic physiology, including obesity, lipid metabolism, insulin resistance, and diabetes, gene knockout (KO) in mice is the ideal platform for both hypothesis testing and discovery of new PPAR functions in vivo. With the fervent pursuit of the magic bullet to eradicate the obesity epidemic, special emphasis has been placed on the impacts of PPARs on obesity and its associated diseases. As detailed in this review, understanding how PPARs regulate gene expression and basic metabolic pathways is a necessary intermediate en route to deciphering their effects on obesity. Over a decade and dozens of genetic modifications of PPARs into this effort, valuable lessons have been learned, but we are left with more questions to be answered. These lessons and future prospects are the subject of this review.
引用
收藏
页数:12
相关论文
共 93 条
[21]   Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-γ both induce cardiac hypertrophy in mice [J].
Duan, SZ ;
Ivashchenko, CY ;
Russell, MW ;
Milstone, DS ;
Mortensen, RM .
CIRCULATION RESEARCH, 2005, 97 (04) :372-379
[22]   The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus [J].
Finck, BN ;
Lehman, JJ ;
Leone, TC ;
Welch, MJ ;
Bennett, MJ ;
Kovacs, A ;
Han, XL ;
Gross, RW ;
Kozak, R ;
Lopaschuk, GD ;
Kelly, DP .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (01) :121-130
[23]   A potential link between muscle peroxisome proliferator-activated receptor-α signaling and obesity-related diabetes [J].
Finck, BN ;
Bernal-Mizrachi, C ;
Han, DH ;
Coleman, T ;
Sambandam, N ;
LaRiviere, LL ;
Holloszy, JO ;
Semenkovich, CF ;
Kelly, DP .
CELL METABOLISM, 2005, 1 (02) :133-144
[24]   15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2) IS A LIGAND FOR THE ADIPOCYTE DETERMINATION FACTOR PPAR-GAMMA [J].
FORMAN, BM ;
TONTONOZ, P ;
CHEN, J ;
BRUN, RP ;
SPIEGELMAN, BM ;
EVANS, RM .
CELL, 1995, 83 (05) :803-812
[25]   A dominant negative peroxisome proliferator-activated receptor-γ knock-in mouse exhibits features of the metabolic syndrome [J].
Freedman, BD ;
Lee, EJ ;
Park, Y ;
Jameson, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (17) :17118-17125
[26]   Liver peroxisome proliferator-activated receptor γ contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass [J].
Gavrilova, O ;
Haluzik, M ;
Matsusue, K ;
Cutson, JJ ;
Johnson, L ;
Dietz, KR ;
Nicol, CJ ;
Vinson, C ;
Gonzalez, FJ ;
Reitman, ML .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (36) :34268-34276
[27]   Thiazolidinediones expand body fluid volume through PPARγ stimulation of ENaC-mediated renal salt absorption [J].
Guan, YF ;
Hao, CM ;
Cha, DR ;
Rao, R ;
Lu, WD ;
Kohan, DE ;
Magnuson, MA ;
Redha, R ;
Zhang, YH ;
Breyer, MD .
NATURE MEDICINE, 2005, 11 (08) :861-866
[28]   PPAR-α-null mice are protected from high-fat diet-induced insulin resistance [J].
Guerre-Millo, M ;
Rouault, C ;
Poulain, P ;
André, J ;
Poitout, V ;
Peters, JM ;
Gonzalez, FJ ;
Fruchart, JC ;
Reach, G ;
Staels, B .
DIABETES, 2001, 50 (12) :2809-2814
[29]   The metabolic syndrome:: Peroxisome proliferator-activated receptor γ and its therapeutic modulation [J].
Gurnell, M ;
Savage, DB ;
Chatterjee, VKK ;
O'Rahilly, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (06) :2412-2421
[30]   Peroxisome proliferator-activated receptor-α deficiency does not alter insulin sensitivity in mice maintained on regular or high-fat diet:: Hyperinsulinemic-euglycemic clamp studies [J].
Haluzik, M ;
Gavrilova, O ;
Leroith, D .
ENDOCRINOLOGY, 2004, 145 (04) :1662-1667